US2444570A
(en)
|
|
1948-07-06 |
|
Drive for counter numeral wheels |
GB735443A
(en)
|
1952-09-02 |
1955-08-24 |
English Numbering Machines |
Improvements in or relating to counting devices
|
US2828742A
(en)
|
1957-05-02 |
1958-04-01 |
American Home Prod |
Cartridge-needle unit
|
NL300399A
(es)
|
1963-05-02 |
|
|
|
US3318289A
(en)
|
1965-05-11 |
1967-05-09 |
Northern Ind Products |
Bi-stable mechanism
|
CH499734A
(de)
|
1968-07-19 |
1970-11-30 |
Kienzle Apparate Gmbh |
Klinkengesperre als Einrichtungs- und Überholkupplung
|
US3758683A
(en)
|
1971-04-30 |
1973-09-11 |
R Jackson |
Insulin product
|
US4282316A
(en)
|
1979-09-11 |
1981-08-04 |
Modrovich Ivan Endre |
Stabilized enzymic solutions for determining urea
|
GR73038B
(es)
|
1980-03-21 |
1984-01-26 |
Wellcome Found |
|
US4425346A
(en)
|
1980-08-01 |
1984-01-10 |
Smith And Nephew Associated Companies Limited |
Pharmaceutical compositions
|
GB2109690B
(en)
|
1981-02-12 |
1985-02-20 |
Robert Charles Turner |
Dose metering plunger devices for use with syringes
|
US4568335A
(en)
|
1981-08-28 |
1986-02-04 |
Markwell Medical Institute, Inc. |
Device for the controlled infusion of medications
|
DE3204178C2
(de)
|
1982-02-06 |
1986-03-20 |
Eppendorf Gerätebau Netheler + Hinz GmbH, 2000 Hamburg |
Pipettiervorrichtung
|
US4483849A
(en)
|
1983-01-07 |
1984-11-20 |
Carter William A |
Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product
|
GB2141799B
(en)
|
1983-06-03 |
1986-07-16 |
Diehl Gmbh & Co |
An adjusting ratchet mechanism for a time switch
|
DE3468173D1
(en)
|
1983-09-07 |
1988-02-04 |
Disetronic Ag |
Portable infusion apparatus
|
US4468346A
(en)
|
1983-10-27 |
1984-08-28 |
The United States Of America As Represented By The Secretary Of Agriculture |
Monoclonal antibodies to porcine immunoglobulins
|
JPS60129941U
(ja)
|
1984-02-09 |
1985-08-31 |
テルモ株式会社 |
医療用器具
|
US4592745A
(en)
|
1984-02-29 |
1986-06-03 |
Novo Industri A/S |
Dispenser
|
FR2583291A1
(fr)
|
1985-06-14 |
1986-12-19 |
Hazon Bernard |
Dispositif d'avancement pas a pas du piston de seringues par double vis coaxiale avec controle du debit d'injection. application aux injections medicamenteuses intra-dermiques repetitives
|
DE3546150A1
(de)
|
1985-06-24 |
1987-01-22 |
Hoechst Ag |
Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
|
BR8606965A
(pt)
|
1985-11-08 |
1987-11-03 |
Disetronic Ag |
Aparelho injetor
|
DE3609555A1
(de)
|
1986-03-21 |
1987-09-24 |
Josef Porner |
Blutentnahmespritze
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
WO1987006941A1
(en)
|
1986-05-05 |
1987-11-19 |
The General Hospital Corporation |
Insulinotropic hormone
|
US4917685A
(en)
|
1986-05-16 |
1990-04-17 |
International Minerals & Chem. Corp. |
Delivery device for the administration of stabilized growth promoting hormones
|
DE3645245C2
(de)
|
1986-11-14 |
1994-01-27 |
Haselmeier Wilhelm Fa |
Injektionsgerät
|
US5716990A
(en)
|
1987-03-09 |
1998-02-10 |
Cancer Research Campaign Technology Limited |
Drug delivery systems
|
DK177187A
(da)
|
1987-04-07 |
1988-10-08 |
Dcp Af 1988 As |
Doseringsenhed til dosering af et antal afmaalte maengder af en vaeske, saasom insulin, fra en glasampul
|
DE3715258C2
(de)
|
1987-05-08 |
1996-10-31 |
Haselmeier Wilhelm Fa |
Injektionsgerät
|
EP0368864B1
(en)
|
1987-05-14 |
1993-11-03 |
Commonwealth Scientific And Industrial Research Organisation |
Whey protein fractions
|
GB8713810D0
(en)
|
1987-06-12 |
1987-07-15 |
Hypoguard Uk Ltd |
Measured dose dispensing device
|
FI883338A
(fi)
|
1987-07-16 |
1989-01-17 |
Bristol Myers Co |
Vattenloesningar av doxorubicinhydroklorid.
|
IT1222331B
(it)
|
1987-08-25 |
1990-09-05 |
Bruno Micovilovich |
Siringa di sicurezza per usi parentali,a disimpegno autonomo e rapido dell'ago dopo l'uso
|
US4919596A
(en)
|
1987-12-04 |
1990-04-24 |
Pacesetter Infusion, Ltd. |
Fluid delivery control and monitoring apparatus for a medication infusion system
|
US4833379A
(en)
|
1988-01-13 |
1989-05-23 |
Sherwood Medical Company |
Motor control fail-safe circuit
|
CH675078A5
(es)
|
1988-01-22 |
1990-08-31 |
Nosta Ag |
|
DE3900926C2
(de)
|
1988-02-08 |
1999-05-12 |
Disetronic Licensing Ag |
Spritzenförmiges Injektionsgerät und Injektionsgerätebaukasten
|
DK166948B1
(da)
|
1988-02-10 |
1993-08-09 |
Dcp Af 1988 As |
Doseringsenhed til dosering af et antal afmaalte maengder af en vaeske, saasom insulin, fra en glastubule
|
US4973318A
(en)
|
1988-02-10 |
1990-11-27 |
D.C.P. Af 1988 A/S |
Disposable syringe
|
EP0422124A4
(en)
|
1988-06-27 |
1991-10-16 |
Genex Corporation |
Thermal release of recombinant protein into culture media
|
ES2069558T3
(es)
|
1988-09-12 |
1995-05-16 |
Graesslin Kg |
Dispositivo para regular el tiempo de un reloj conmutador.
|
GB8900763D0
(en)
|
1989-01-13 |
1989-03-08 |
Kabi Vitrum Peptide Hormones A |
Multi-dose syringe
|
US5216437A
(en)
|
1989-02-02 |
1993-06-01 |
Canon Kabushiki Kaisha |
Ink, and recording method making use of same
|
DK68789A
(da)
|
1989-02-14 |
1990-08-15 |
Novo Nordisk As |
Injektionspen
|
HU203372B
(en)
|
1989-02-24 |
1991-07-29 |
Richter Gedeon Vegyeszet |
Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
|
ATE193541T1
(de)
|
1989-03-20 |
2000-06-15 |
Gen Hospital Corp |
Insulinotropes hormon
|
JP2822447B2
(ja)
|
1989-05-19 |
1998-11-11 |
住友電気工業株式会社 |
酸化物超電導線材の製造方法および装置
|
US4994033A
(en)
|
1989-05-25 |
1991-02-19 |
Schneider (Usa) Inc. |
Intravascular drug delivery dilatation catheter
|
US5226895A
(en)
|
1989-06-05 |
1993-07-13 |
Eli Lilly And Company |
Multiple dose injection pen
|
DE3927286C2
(de)
|
1989-08-18 |
1997-07-24 |
Roehm Gmbh |
Wäßrige Enzym-Flüssigformulierungen
|
US5216011A
(en)
|
1989-09-01 |
1993-06-01 |
Bristol-Myers Squibb Co. |
Stable solutions of mitomycin c
|
EP0431679B1
(en)
|
1989-12-05 |
1994-10-19 |
Merck & Co. Inc. |
Method of stabilizing recombinant hepatitis B virus surface proteins from yeast
|
DK17890A
(da)
|
1990-01-22 |
1991-07-23 |
Novo Nordisk As |
Fremgangsmaade og apparat til opblanding og injicering af et laegemiddel
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
EP0512042B1
(en)
|
1990-01-24 |
1998-04-08 |
BUCKLEY, Douglas I. |
Glp-1 analogs useful for diabetes treatment
|
DE4002066A1
(de)
|
1990-01-25 |
1991-08-01 |
Basf Ag |
Verfahren zur abtrennung von riboflavin aus fermentationssuspensionen
|
GB9007113D0
(en)
|
1990-03-29 |
1990-05-30 |
Sams Bernard |
Dispensing device
|
US5207752A
(en)
|
1990-03-30 |
1993-05-04 |
Alza Corporation |
Iontophoretic drug delivery system with two-stage delivery profile
|
US5318540A
(en)
|
1990-04-02 |
1994-06-07 |
Pharmetrix Corporation |
Controlled release infusion device
|
US5492534A
(en)
|
1990-04-02 |
1996-02-20 |
Pharmetrix Corporation |
Controlled release portable pump
|
US5226896A
(en)
|
1990-04-04 |
1993-07-13 |
Eli Lilly And Company |
Dose indicating injection pen
|
IT220491Z2
(it)
|
1990-04-13 |
1993-09-24 |
Stilolinea Srl |
Penna a sfera del tipo a punta scrivente rientrante
|
ES2117642T3
(es)
|
1990-05-10 |
1998-08-16 |
Bechgaard Int Res |
Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
|
US5257987A
(en)
|
1990-05-21 |
1993-11-02 |
Pharmetrix Corporation |
Controlled release osmotic infusion system
|
JP3042710B2
(ja)
|
1990-09-21 |
2000-05-22 |
ノボ ノルディスク アクティーゼルスカブ |
ペンシリンジアセンブリー
|
US5284480A
(en)
|
1990-11-09 |
1994-02-08 |
Medtronic, Inc. |
Inflation/deflation syringe with threaded plunger
|
GB9026191D0
(en)
|
1990-12-01 |
1991-01-16 |
Harris Pharma Ltd |
Breath actuated dispensing device
|
US5331954A
(en)
|
1990-12-21 |
1994-07-26 |
Novo Nordisk A/S |
Device for nasal delivery of liquid medications
|
US5232706A
(en)
|
1990-12-31 |
1993-08-03 |
Esteve Quimica, S.A. |
Oral pharmaceutical preparation containing omeprazol
|
AU641206B2
(en)
|
1991-01-22 |
1993-09-16 |
Eli Lilly And Company |
Multiple dose injection pen
|
EP0498737B1
(en)
|
1991-02-07 |
1995-07-19 |
Terumo Kabushiki Kaisha |
Dosing means for an injector
|
US5272135A
(en)
|
1991-03-01 |
1993-12-21 |
Chiron Ophthalmics, Inc. |
Method for the stabilization of methionine-containing polypeptides
|
HU222249B1
(hu)
|
1991-03-08 |
2003-05-28 |
Amylin Pharmaceuticals Inc. |
Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
|
ATE167229T1
(de)
|
1991-03-27 |
1998-06-15 |
Novo Nordisk As |
Katalase, ihre herstellung und verwendung
|
US5258377A
(en)
|
1991-04-08 |
1993-11-02 |
Taiho Pharmaceutical Co., Ltd. |
2-spirocyclopropyl 4-acylcephems
|
DE4112259A1
(de)
|
1991-04-15 |
1992-10-22 |
Medico Dev Investment Co |
Injektionsgeraet
|
DK68991D0
(da)
|
1991-04-17 |
1991-04-17 |
Novo Nordisk As |
Manifold
|
US5645052A
(en)
|
1991-04-26 |
1997-07-08 |
The Boc Group Plc |
Anaesthetic vaporizer with expandable/contractable reservoir for pumping liquid anaesthetic
|
SE9101381D0
(sv)
|
1991-05-07 |
1991-05-07 |
Tomas Moks |
Peptide hormone solution
|
DK0525525T3
(da)
|
1991-07-24 |
1995-10-02 |
Medico Dev Investment Co |
Injektor
|
DK175491D0
(da)
|
1991-10-18 |
1991-10-18 |
Novo Nordisk As |
Apparat
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
AU3156493A
(en)
|
1991-11-29 |
1993-06-28 |
Novo Nordisk A/S |
A pen-shaped syringe
|
DK194291D0
(da)
|
1991-11-29 |
1991-11-29 |
Novo Nordisk As |
Sproejte til automatisk injektion.
|
US5246417A
(en)
|
1991-12-11 |
1993-09-21 |
Alza Corporation |
Indicator for iontophoresis system
|
US5849700A
(en)
|
1991-12-20 |
1998-12-15 |
Novo Nordisk A/S |
Pharmaceutical formulation
|
FR2686460B1
(fr)
|
1992-01-20 |
1994-03-11 |
Labinal Precision Mecanique |
Organe de contact electrique femelle.
|
US5279586A
(en)
|
1992-02-04 |
1994-01-18 |
Becton, Dickinson And Company |
Reusable medication delivery pen
|
CH682968B5
(fr)
|
1992-02-12 |
1994-06-30 |
Rolex Montres |
Procédé de fabrication d'un joint et joint pour dispositif de commande étanche pour montre obtenu selon ce procédé.
|
CH682806A5
(de)
|
1992-02-21 |
1993-11-30 |
Medimpex Ets |
Injektionsgerät.
|
DE4208677A1
(de)
|
1992-03-18 |
1993-09-23 |
Injecta Gmbh Steinach |
Injektionsvorrichtung, insbesondere fuer sehgeschaedigte diabetiker
|
DK36492D0
(da)
|
1992-03-19 |
1992-03-19 |
Novo Nordisk As |
Praeparat
|
DK39892D0
(da)
|
1992-03-25 |
1992-03-25 |
Bernard Thorens |
Peptid
|
WO1993018812A1
(en)
|
1992-03-25 |
1993-09-30 |
Tebro S.A. |
Powder jet dispenser for medicament inhalation therapies
|
US5271527A
(en)
|
1992-04-02 |
1993-12-21 |
Habley Medical Technology Corporation |
Reusable pharmaceutical dispenser with full stroke indicator
|
US5281198A
(en)
|
1992-05-04 |
1994-01-25 |
Habley Medical Technology Corporation |
Pharmaceutical component-mixing delivery assembly
|
EP0642332B1
(en)
|
1992-05-13 |
1997-01-15 |
Sandoz Ltd. |
Ophthalmic compositions containing a cyclosporin
|
CZ315594A3
(en)
|
1992-06-15 |
1995-07-12 |
Pfizer |
Peptide of glucagon type, insulinotropic derivatives, process of their preparation, pharmaceutical composition containing such compounds and use
|
UA26190C2
(uk)
|
1992-07-28 |
1999-07-19 |
Сейфтек Ай Лімітед |
Шприц
|
GB9219849D0
(en)
|
1992-09-19 |
1992-10-28 |
Hypoguard Uk Ltd |
Device
|
ES2154651T3
(es)
|
1992-10-15 |
2001-04-16 |
Gen Hospital Corp |
Bomba de infusion con biblioteca de medicamentos cargable electronicamente.
|
US5545147A
(en)
|
1992-10-20 |
1996-08-13 |
Eli Lilly And Company |
Anti-backup improvement for hypodermic syringes
|
US5378233A
(en)
|
1992-11-18 |
1995-01-03 |
Habley Medical Technology Corporation |
Selected dose pharmaceutical dispenser
|
US5320609A
(en)
|
1992-12-07 |
1994-06-14 |
Habley Medical Technology Corporation |
Automatic pharmaceutical dispensing syringe
|
GB9226423D0
(en)
|
1992-12-18 |
1993-02-10 |
Sams Bernard |
Incrementing mechanisms
|
AU678573B2
(en)
|
1993-02-19 |
1997-06-05 |
Medicorp Holding S.A. |
Prefilled syringe for storing and dispensing a sterile liquid drug
|
US5383865A
(en)
|
1993-03-15 |
1995-01-24 |
Eli Lilly And Company |
Medication dispensing device
|
US5584815A
(en)
|
1993-04-02 |
1996-12-17 |
Eli Lilly And Company |
Multi-cartridge medication injection device
|
ZA941881B
(en)
|
1993-04-02 |
1995-09-18 |
Lilly Co Eli |
Manifold medication injection apparatus and method
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
SE9301494D0
(sv)
|
1993-04-30 |
1993-04-30 |
Kabi Pharmacia Ab |
A device for dosing liquid preparation
|
DK52393D0
(es)
|
1993-05-05 |
1993-05-05 |
Novo Nordisk As |
|
AU7531094A
(en)
|
1993-08-24 |
1995-03-21 |
Novo Nordisk A/S |
Protracted glp-1
|
WO1995007931A1
(en)
|
1993-09-17 |
1995-03-23 |
Novo Nordisk A/S |
Acylated insulin
|
GB9320782D0
(en)
|
1993-10-08 |
1993-12-01 |
Univ Leeds Innovations Ltd |
Stabilising of proteins on solution
|
AU8083894A
(en)
|
1993-11-19 |
1995-06-06 |
G.D. Searle & Co. |
Transdermal composition of n-{n-{5-{4-(aminoiminomethyl)phenyl}-1-oxopentyl}-l-alpha-as partyl}-l-phenylalanine or its esters and their pharmaceutically acceptable salts
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
US5478316A
(en)
|
1994-02-02 |
1995-12-26 |
Becton, Dickinson And Company |
Automatic self-injection device
|
US5514097A
(en)
|
1994-02-14 |
1996-05-07 |
Genentech, Inc. |
Self administered injection pen apparatus and method
|
US5562623A
(en)
|
1994-02-14 |
1996-10-08 |
Univec |
Single-use syringe assembly including spring clip lock and plunger
|
WO1995022560A1
(en)
|
1994-02-22 |
1995-08-24 |
The Syntex-Synergen Neuroscience Joint Venture |
Pharmaceutical formulations of cntf
|
WO1995029996A1
(en)
|
1994-05-03 |
1995-11-09 |
Novo Nordisk A/S |
Alkaline glucose oxidase
|
GB9409496D0
(en)
|
1994-05-12 |
1994-06-29 |
London Health Ass |
Method for improving glycaemic control in diabetes
|
US5750140A
(en)
|
1994-05-20 |
1998-05-12 |
Novo Nordisk A/S |
Transdermal delivery of tiagabine
|
US5652216A
(en)
|
1994-05-26 |
1997-07-29 |
Novo Nordisk A/S |
Pharmaceutical preparation
|
AU1595395A
(en)
|
1994-06-15 |
1996-01-05 |
Interventional Research Technologies, Inc. |
Locking device for syringe or like instrument
|
US5461031A
(en)
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5725508A
(en)
|
1994-06-22 |
1998-03-10 |
Becton Dickinson And Company |
Quick connect medication delivery pen
|
US5827232A
(en)
|
1994-06-22 |
1998-10-27 |
Becton Dickinson And Company |
Quick connect medication delivery pen
|
US5440976A
(en)
|
1994-08-23 |
1995-08-15 |
Fred Giuliano |
Adjustable dispensing stirrer for soluble sweeteners
|
WO1996005878A1
(fr)
|
1994-08-24 |
1996-02-29 |
Eli Lilly Japan Kabushiki Kaisha |
Appareil pour injections
|
US5549574A
(en)
|
1994-08-30 |
1996-08-27 |
Eli Lilly And Company |
Cartridge assembly for use in a pen-type medicament injector
|
US5574008A
(en)
|
1994-08-30 |
1996-11-12 |
Eli Lilly And Company |
Biologically active fragments of glucagon-like insulinotropic peptide
|
DE69532492T2
(de)
|
1994-08-31 |
2004-12-02 |
Mitsubishi Pharma Corp. |
Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin
|
CN1157553A
(zh)
|
1994-09-09 |
1997-08-20 |
诺沃挪第克公司 |
清洁、消毒和防护隐形眼镜的方法
|
US5549575A
(en)
|
1994-09-13 |
1996-08-27 |
Becton Dickinson And Company |
Cartridge retainer assembly for medication delivery pen
|
US5582598A
(en)
|
1994-09-19 |
1996-12-10 |
Becton Dickinson And Company |
Medication delivery pen with variable increment dose scale
|
DK0782393T3
(da)
|
1994-09-20 |
1998-09-07 |
Slagteriselskabet Danish Crown |
Fremgangsmåde til behandling ag en vandig proteinopløsning for at dræbe mikroorganismer deri uden atbevirke koagulering
|
ZA958073B
(en)
|
1994-09-28 |
1996-04-23 |
Anthony William Manicom |
Method of and apparatus for administering a drug to a patient
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
ATE234625T1
(de)
|
1994-12-23 |
2003-04-15 |
Novo Nordisk As |
Glp-1 zusammensetzungen mit verlängerter wirkdauer
|
MX9705906A
(es)
|
1995-02-03 |
1997-10-31 |
Novo Nordisk As |
Un metodo para diseñar mutantes de alfa-amilasa con propiedades predeterminadas.
|
AU695129B2
(en)
|
1995-02-06 |
1998-08-06 |
Genetics Institute, Llc |
Formulations for IL-12
|
GB9503969D0
(en)
|
1995-02-28 |
1995-04-19 |
Sams Bernard |
Incrementing mechanism
|
WO1996027400A1
(en)
|
1995-03-07 |
1996-09-12 |
Eli Lilly And Company |
Recyclable medication dispensing device
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
WO1996029344A1
(en)
|
1995-03-17 |
1996-09-26 |
Novo Nordisk A/S |
Insulin derivatives
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
US6184201B1
(en)
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
EP0828753B1
(en)
|
1995-06-02 |
2003-03-26 |
Novozymes A/S |
Al/Fe-TREATMENT OF A PROTEIN SOLUTION, FOLLOWED BY MEMBRANE CONCENTRATION
|
AU705105B2
(en)
|
1995-06-02 |
1999-05-13 |
Novo Nordisk A/S |
Automatic withdrawal of piston rod
|
US5631347A
(en)
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
CA2222329C
(en)
|
1995-06-13 |
2007-10-23 |
Novo Nordisk A/S |
4-substituted-phenyl-boronic acids as enzyme stabilizers
|
US5674204A
(en)
|
1995-09-19 |
1997-10-07 |
Becton Dickinson And Company |
Medication delivery pen cap actuated dose delivery clutch
|
US5688251A
(en)
|
1995-09-19 |
1997-11-18 |
Becton Dickinson And Company |
Cartridge loading and priming mechanism for a pen injector
|
JP3060287B2
(ja)
|
1995-10-09 |
2000-07-10 |
参天製薬株式会社 |
アパファントを主薬とする水性点眼剤
|
US5899879A
(en)
|
1995-12-19 |
1999-05-04 |
Genesis Medical Technologies, Inc. |
Spring-actuated needleless injector
|
DK0959922T3
(da)
|
1996-02-23 |
2003-09-01 |
Novo Nordisk As |
Sprøjte med elektronisk repræsentation af parametre
|
EP0885014B1
(en)
|
1996-03-05 |
2002-10-23 |
Robert Gurny |
Pharmaceutical compositions containing buffered ortho ester polymers
|
DE69735089T2
(de)
|
1996-03-12 |
2006-08-31 |
Novo Nordisk A/S |
Injektionsvorrichtung mit elektronischer anzeige von eingestellten dosierungen
|
EP0828527B1
(de)
|
1996-04-02 |
2002-07-31 |
Disetronic Licensing AG |
Injektionsgerät
|
JP2001527435A
(ja)
|
1996-04-24 |
2001-12-25 |
ノボ ノルディスク アクティーゼルスカブ |
注射針
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
NZ333580A
(en)
|
1996-07-03 |
2000-06-23 |
Alza Corp |
Non-Aqueous protic peptide formulations, preferably LHRH
|
AU3335697A
(en)
|
1996-07-05 |
1998-02-02 |
Novo Nordisk A/S |
Automatic needle insertion mechanism
|
KR20000022349A
(ko)
|
1996-07-05 |
2000-04-25 |
한센 핀 베네드;안네 제헤르 |
투여량 세팅장치
|
CA2258309A1
(en)
|
1996-07-05 |
1998-01-15 |
Novo Nordisk A/S |
Flexible piston rod
|
US5981489A
(en)
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
US5962407A
(en)
|
1996-07-26 |
1999-10-05 |
Kelly; Michael T. |
Loloatin derivatives and analogs
|
DE69739172D1
(de)
|
1996-08-08 |
2009-01-29 |
Amylin Pharmaceuticals Inc |
Regulation gastrointestinaler beweglichkeit
|
JPH10101696A
(ja)
|
1996-08-08 |
1998-04-21 |
Shinotesuto:Kk |
形質転換体にて発現される蛋白質に含まれる夾雑物質の除去方法及び精製蛋白質
|
US5843036A
(en)
|
1996-08-23 |
1998-12-01 |
Becton Dickinson And Company |
Non-dosing cartridge for an injection device
|
US5709662A
(en)
|
1996-08-23 |
1998-01-20 |
Becton Dickinson France, S.A. |
Cartridge for an injection device
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
CZ300837B6
(cs)
|
1996-08-30 |
2009-08-26 |
Novo Nordisk A/S |
Deriváty GLP-1(7-37) nebo jeho analogy, farmaceutický prostredek je obsahující a jejich použití
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6006753A
(en)
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6384016B1
(en)
|
1998-03-13 |
2002-05-07 |
Novo Nordisk A/S |
Stabilized aqueous peptide solutions
|
US6277819B1
(en)
|
1996-08-30 |
2001-08-21 |
Eli Lilly And Company |
Use of GLP-1 or analogs in treatment of myocardial infarction
|
US6110149A
(en)
|
1996-09-13 |
2000-08-29 |
Novo Nordisk A/S |
Syringe
|
CZ87799A3
(cs)
|
1996-09-13 |
1999-06-16 |
Novo Nordisk A/S |
Dávkovací zobrazovací jednotka pro injekční stříkačku
|
US6379339B1
(en)
|
1996-09-13 |
2002-04-30 |
Nova Nordisk A/S |
Syringe
|
US5947934A
(en)
|
1996-09-13 |
1999-09-07 |
Novo Nordisk A/S |
Dose display for an injection syringe
|
JP2001501504A
(ja)
|
1996-09-20 |
2001-02-06 |
ノボ ノルディスク アクティーゼルスカブ |
作動シリンダ
|
US6146361A
(en)
|
1996-09-26 |
2000-11-14 |
Becton Dickinson And Company |
Medication delivery pen having a 31 gauge needle
|
US5908830A
(en)
|
1996-10-31 |
1999-06-01 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes and obesity
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
TW524667B
(en)
|
1996-12-05 |
2003-03-21 |
Pfizer |
Parasiticidal pyrazoles
|
US5954689A
(en)
|
1996-12-20 |
1999-09-21 |
Novo Nordisk A/S |
Jet injector
|
ES2425559T5
(es)
|
1997-01-07 |
2018-02-02 |
Amylin Pharmaceuticals, Llc |
Composiciones farmacéuticas que comprenden las exendinas y los agonistas de las mismas
|
US7312196B2
(en)
|
1997-01-08 |
2007-12-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
US6136784A
(en)
|
1997-01-08 |
2000-10-24 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
TW503113B
(en)
|
1997-01-16 |
2002-09-21 |
Senju Pharma Co |
Aqueous suspension for nasal administration
|
US6274553B1
(en)
|
1997-01-20 |
2001-08-14 |
Japan Energy Corporation |
Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method
|
GB2321419B
(en)
|
1997-01-27 |
2001-02-07 |
Medic Aid Ltd |
Atomizer
|
EP0971760A1
(en)
|
1997-02-04 |
2000-01-19 |
Novo Nordisk A/S |
A device for the administration of a liquid medicament suspension
|
DE29703820U1
(de)
|
1997-03-03 |
1998-07-02 |
Medico Dev Investment Co |
Injektionsgerät
|
US5898028A
(en)
|
1997-03-20 |
1999-04-27 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
US20010020155A1
(en)
|
1997-03-25 |
2001-09-06 |
Soren Mikkelsen |
Injection system
|
WO1998043658A1
(en)
|
1997-03-31 |
1998-10-08 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
CA2236519C
(en)
|
1997-05-02 |
2011-09-13 |
1149336 Ontario Inc. |
Methods of enhancing functioning of the large intestine
|
US7101853B2
(en)
|
1997-05-06 |
2006-09-05 |
Amylin Pharmaceuticals, Inc. |
Method for treating or preventing gastritis using amylin or amylin agonists
|
RU2111019C1
(ru)
|
1997-05-22 |
1998-05-20 |
Сергей Александрович Хворостов |
Универсальный инъектор
|
PT983300E
(pt)
|
1997-05-23 |
2005-02-28 |
Udovicic Ivan |
Sais peptidicos de bpc com actividade organo-protectora, processo para a sua preparacao e sua utilizacao em terapia
|
US7910548B2
(en)
|
1997-06-06 |
2011-03-22 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity
|
US6003736A
(en)
|
1997-06-09 |
1999-12-21 |
Novo Nordisk A/S |
Device for controlled dispensing of a dose of a liquid contained in a cartridge
|
WO1998056381A1
(en)
|
1997-06-09 |
1998-12-17 |
Bridge Pharma, Inc. |
Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
|
US6074372A
(en)
|
1997-06-09 |
2000-06-13 |
Novo Nordisk A/S |
Dose setting mechanism and an injection syringe having such a dose setting mechanism
|
CO4750643A1
(es)
|
1997-06-13 |
1999-03-31 |
Lilly Co Eli |
Formulacion estable de la insulina que contiene l-arginina y protamina
|
US5961496A
(en)
|
1997-06-17 |
1999-10-05 |
Novo Nordisk A/S |
Syringe with tiltable nut for quick piston disengagement
|
US6796970B1
(en)
|
1997-06-17 |
2004-09-28 |
Novo Nordisk A/S |
Dose setting device
|
JP3503129B2
(ja)
|
1997-06-30 |
2004-03-02 |
荒川化学工業株式会社 |
カラーフィルタ層用剥離剤およびカラーフィルタ用ガラス基板の再生方法
|
EP1015050A1
(en)
|
1997-07-11 |
2000-07-05 |
Novo Nordisk A/S |
An apparatus for the registration of the setting of a medical device
|
WO1999003520A1
(en)
|
1997-07-14 |
1999-01-28 |
Novo Nordisk A/S |
Cylinder ampoule
|
AU8333398A
(en)
|
1997-07-14 |
1999-02-10 |
Novo Nordisk A/S |
Injection member
|
DE19730999C1
(de)
|
1997-07-18 |
1998-12-10 |
Disetronic Licensing Ag |
Dosierknopfsicherung an einer Vorrichtung zur dosierten Verabreichung eines injizierbaren Produkts
|
US5921966A
(en)
|
1997-08-11 |
1999-07-13 |
Becton Dickinson And Company |
Medication delivery pen having an improved clutch assembly
|
FR2767479B1
(fr)
|
1997-08-22 |
1999-10-22 |
Aguettant Lab |
Dispositif d'injection de medicament
|
WO1999016485A1
(en)
|
1997-09-29 |
1999-04-08 |
Becton Dickinson And Company |
Injection device and drug cartridge for preventing cross-use of the device and drug cartridge
|
EP2042161A1
(en)
|
1997-10-01 |
2009-04-01 |
Novadel Pharma Inc. |
Propellant-free spray composition comprising anti-emetic agent
|
EP1025125B1
(en)
|
1997-10-24 |
2003-06-25 |
Novo Nordisk A/S |
Aggregates of human insulin derivatives
|
JP4239131B2
(ja)
|
1997-10-24 |
2009-03-18 |
ジェネンテック・インコーポレーテッド |
分子の精製
|
US6312413B1
(en)
|
1997-10-30 |
2001-11-06 |
Novo Nordisk A/S |
Cylinder ampoule
|
CA2312190A1
(en)
|
1997-12-05 |
1999-06-17 |
Eli Lilly And Company |
Glp-1 formulations
|
MY120063A
(en)
|
1997-12-09 |
2005-08-30 |
Lilly Co Eli |
Stabilized teriparatide solutions
|
DE29721752U1
(de)
|
1997-12-09 |
1998-02-12 |
Siemens Ag |
Crimpkontakt für Stecksysteme
|
US6380357B2
(en)
|
1997-12-16 |
2002-04-30 |
Eli Lilly And Company |
Glucagon-like peptide-1 crystals
|
JPH11249087A
(ja)
|
1997-12-18 |
1999-09-17 |
Tome:Kk |
コンタクトレンズ用液剤
|
JP4353544B2
(ja)
|
1998-01-09 |
2009-10-28 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
アミリン作動薬ペプチド用製剤
|
WO1999034764A2
(en)
|
1998-01-09 |
1999-07-15 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
CA2284847A1
(en)
|
1998-01-30 |
1999-08-05 |
Suntory Limited |
Process for producing peptides using a helper peptide
|
UA56256C2
(uk)
|
1998-01-30 |
2003-05-15 |
Ново Нордіск А/С |
Шприц для ін'єкцій
|
DE69943039D1
(de)
|
1998-02-13 |
2011-01-27 |
Amylin Pharmaceuticals Inc |
Neue verbindungen mit gemischter amylin aktivität
|
JP4677095B2
(ja)
|
1998-02-13 |
2011-04-27 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
エキセンジンおよびglp−1の変力および利尿効果
|
WO1999040966A1
(en)
|
1998-02-13 |
1999-08-19 |
Graham Francois Duirs |
Drug delivery system
|
US6221053B1
(en)
|
1998-02-20 |
2001-04-24 |
Becton, Dickinson And Company |
Multi-featured medication delivery pen
|
US5961495A
(en)
|
1998-02-20 |
1999-10-05 |
Becton, Dickinson And Company |
Medication delivery pen having a priming mechanism
|
US6248095B1
(en)
|
1998-02-23 |
2001-06-19 |
Becton, Dickinson And Company |
Low-cost medication delivery pen
|
WO1999043708A1
(en)
|
1998-02-27 |
1999-09-02 |
Novo Nordisk A/S |
Glp-1 derivatives of glp-1 and exendin with protracted profile of action
|
EP1062240B1
(en)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
N-terminally modified glp-1 derivatives
|
JP2002504518A
(ja)
|
1998-02-27 |
2002-02-12 |
ノボ ノルディスク アクティーゼルスカブ |
部分的に構造化されたミセルー様凝集体を形成する、25%を超えるヘリックス−含有率を有するglp−1誘導体
|
AU2610699A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Derivatives of glp-1 analogs
|
AU2610599A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
N-terminally truncated glp-1 derivatives
|
JP4072319B2
(ja)
|
1998-03-13 |
2008-04-09 |
ノヴォ ノルディスク アクティーゼルスカブ |
安定化水溶性ペプチド溶液
|
AU3772199A
(en)
|
1998-05-01 |
1999-11-23 |
University Of Tennessee Research Corporation, The |
Flow cytometric characterization of amyloid fibrils
|
CA2332314A1
(en)
|
1998-06-11 |
1999-12-16 |
Cerus Corporation |
Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
|
IL140527A0
(en)
|
1998-07-08 |
2002-02-10 |
Novo Nordisk As |
A medical delivery device and a cartridge assembly for use in the same
|
CN1317967A
(zh)
|
1998-09-17 |
2001-10-17 |
伊莱利利公司 |
蛋白质制剂
|
US6033376A
(en)
|
1998-09-30 |
2000-03-07 |
Allergan Sales, Inc. |
Wound shaper sleeve
|
US6489292B1
(en)
|
1998-11-18 |
2002-12-03 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
US6605067B1
(en)
|
1998-11-20 |
2003-08-12 |
Novo Nordisk A/S |
Injection needle
|
US6375975B1
(en)
|
1998-12-21 |
2002-04-23 |
Generex Pharmaceuticals Incorporated |
Pharmaceutical compositions for buccal and pulmonary application
|
ATE307603T1
(de)
|
1998-12-22 |
2005-11-15 |
Lilly Co Eli |
Lagerstabile flüssige zusammensetzungen von glucagon-ähnlichem peptid-1
|
CN101181236A
(zh)
|
1999-01-14 |
2008-05-21 |
安米林药品公司 |
新型exendin激动剂制剂及其给药方法
|
DE29900482U1
(de)
|
1999-01-14 |
2000-08-31 |
Medico Dev Investment Co |
Injektionsgerät
|
EP1071517B1
(de)
|
1999-02-14 |
2008-04-02 |
Ing. Erich Pfeiffer GmbH |
Spender für fliessfähige medien
|
US6258062B1
(en)
|
1999-02-25 |
2001-07-10 |
Joseph M. Thielen |
Enclosed container power supply for a needleless injector
|
US6444788B1
(en)
|
1999-03-15 |
2002-09-03 |
Novo Nordisk A/S |
Ion exchange chromatography of GLP-1, analogs and derivatives thereof
|
PL351326A1
(en)
|
1999-03-17 |
2003-04-07 |
Novo Nordisk As |
Method for acylating peptides and novel acylating agents
|
SE9901366D0
(sv)
|
1999-04-16 |
1999-04-16 |
Pharmacia & Upjohn Ab |
Injector device and method for its operation
|
FR2793684B1
(fr)
|
1999-05-17 |
2001-08-10 |
Ethypharm Lab Prod Ethiques |
Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
WO2001001774A1
(en)
|
1999-06-17 |
2001-01-11 |
Regents Of The University Of California |
Continuous cardiac perfusion preservation with peg-hb for improved hypothermic storage
|
USRE40876E1
(en)
|
1999-06-21 |
2009-08-18 |
Eli Lilly And Company |
Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof
|
CA2369839A1
(en)
|
1999-06-25 |
2001-01-04 |
Minimed, Inc. |
Compositions of insulin and insulin-related peptide for treating diabetes
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
AU6892100A
(en)
|
1999-08-05 |
2001-03-05 |
Becton Dickinson & Company |
Medication delivery pen
|
TW453884B
(en)
|
1999-09-16 |
2001-09-11 |
Novo Nordisk As |
Dose setting limiter
|
DE60024118T2
(de)
|
1999-09-20 |
2006-07-27 |
Eli Lilly And Co., Indianapolis |
Verwendung einer parathyroidhormone zur reduktion des krebsrisikos
|
US6514230B1
(en)
|
1999-10-12 |
2003-02-04 |
Novo Nordisk A/S |
Air shot mechanism for electronic injection devices
|
US6569832B1
(en)
|
1999-11-12 |
2003-05-27 |
Novo Nordisk A/S |
Inhibition of beta cell degeneration
|
EA004631B1
(ru)
|
1999-12-16 |
2004-06-24 |
Эли Лилли Энд Компани |
Полипептидные композиции, обладающие повышенной стабильностью
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
GB9930882D0
(en)
|
1999-12-30 |
2000-02-23 |
Nps Allelix Corp |
GLP-2 formulations
|
EP1250126A2
(en)
|
2000-01-11 |
2002-10-23 |
Novo Nordisk A/S |
Transepithelial delivery of glp-1 derivatives
|
US6734162B2
(en)
|
2000-01-24 |
2004-05-11 |
Minimed Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
AU2001232735A1
(en)
|
2000-01-27 |
2001-08-07 |
Eli Lilly And Company |
Process for solubilizing glucagon-like peptide 1 compounds
|
EP1396499A3
(en)
|
2000-01-27 |
2004-12-29 |
Eli Lilly And Company |
Process for solubilizing glucagon-like peptide 1 (GLP-1) compounds
|
US6569901B2
(en)
|
2000-01-28 |
2003-05-27 |
Novo Nordisk A/S |
Alkynyl-substituted propionic acid derivatives, their preparation and use
|
US6844321B2
(en)
|
2000-01-31 |
2005-01-18 |
Novo Nordisk A/S |
Crystallization of a GLP-1 analogue
|
GB0007071D0
(en)
|
2000-03-24 |
2000-05-17 |
Sams Bernard |
One-way clutch mechanisms and injector devices
|
AU2001248277A1
(en)
|
2000-04-06 |
2001-10-23 |
Novo-Nordisk A/S |
Shock heat treatment of polypeptides
|
US6692472B2
(en)
|
2000-05-04 |
2004-02-17 |
Novo Nordisk A/S |
Injection device, a preassembled dose setting and injection mechanism for an injection device, and a method of assembling an injection device
|
US20020061838A1
(en)
|
2000-05-17 |
2002-05-23 |
Barton Holmquist |
Peptide pharmaceutical formulations
|
US6547763B2
(en)
|
2000-05-18 |
2003-04-15 |
Novo Nordisk A/S |
Dose display for injection device
|
US6716198B2
(en)
|
2000-05-18 |
2004-04-06 |
Novo Nordisk A/S |
Injection device
|
US6547764B2
(en)
|
2000-05-31 |
2003-04-15 |
Novo Nordisk A/S |
Double pointed injection needle
|
US6663602B2
(en)
|
2000-06-16 |
2003-12-16 |
Novo Nordisk A/S |
Injection device
|
KR100847615B1
(ko)
|
2000-06-16 |
2008-07-21 |
일라이 릴리 앤드 캄파니 |
글루카곤-유사 펩티드-1 유사체
|
US6369419B1
(en)
|
2000-06-23 |
2002-04-09 |
International Business Machines Corporation |
Self-aligned near surface strap for high density trench DRAMS
|
JP2004503337A
(ja)
|
2000-07-14 |
2004-02-05 |
ノボ ノルディスク アクティーゼルスカブ |
液体薬物射出装置及び所望の投与量を射出させる方法
|
WO2002024257A1
(en)
|
2000-09-22 |
2002-03-28 |
Novo Nordisk A/S |
A medication delivery device
|
JP4798833B2
(ja)
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
加熱処理工程を含むヒト血清アルブミンの製造方法
|
MXPA03005036A
(es)
|
2000-12-07 |
2003-09-05 |
Lilly Co Eli |
Proteinas de fusion glp-1.
|
JP2004521093A
(ja)
|
2000-12-13 |
2004-07-15 |
イーライ・リリー・アンド・カンパニー |
グルカゴン様インスリン刺激性ペプチドを用いる長期治療計画
|
WO2002048192A2
(en)
|
2000-12-13 |
2002-06-20 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
US20020151467A1
(en)
|
2000-12-21 |
2002-10-17 |
Leung Frank K. |
Methods and compositions for oral insulin delivery
|
US6899699B2
(en)
|
2001-01-05 |
2005-05-31 |
Novo Nordisk A/S |
Automatic injection device with reset feature
|
GB2371227A
(en)
|
2001-01-10 |
2002-07-24 |
Grandis Biotech Gmbh |
Crystallisation - resistant aqueous growth hormone formulations
|
WO2002064196A1
(en)
|
2001-02-14 |
2002-08-22 |
Novo Nordisk A/S |
Electronically controlled injection or infusion device
|
JP4280070B2
(ja)
|
2001-02-16 |
2009-06-17 |
コンジュケム バイオテクノロジーズ インコーポレイテッド |
胃腸疾患および胃腸障害の処置のための長期持続性グルカゴン様ペプチド2(glp−2)
|
JP2004518756A
(ja)
|
2001-03-07 |
2004-06-24 |
ノボ ノルディスク アクティーゼルスカブ |
Glp−1類似体およびpparリガンドの誘導体の組み合わせ使用
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
EP1392377B1
(en)
|
2001-05-16 |
2007-02-28 |
Eli Lilly And Company |
Medication injector apparatus with drive assembly that facilitates reset
|
WO2002098445A1
(en)
|
2001-05-30 |
2002-12-12 |
Chugai Seiyaku Kabushiki Kaisha |
Protein preparation
|
GB0113881D0
(en)
|
2001-06-07 |
2001-08-01 |
Innovate Biomed Ltd |
Foil cutting system
|
AU2002316811A1
(en)
|
2001-06-28 |
2003-03-03 |
Novo Nordisk A/S |
Stable formulation of modified glp-1
|
US6872705B2
(en)
|
2001-07-13 |
2005-03-29 |
Allergan, Inc. |
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
|
DE10163326A1
(de)
|
2001-07-30 |
2003-02-27 |
Disetronic Licensing Ag |
Verabreichungsgerät mit Dosiervorrichtung
|
CN1335182A
(zh)
|
2001-08-08 |
2002-02-13 |
华中科技大学 |
胰岛素口腔喷剂及其制备工艺
|
WO2003020201A2
(en)
|
2001-08-28 |
2003-03-13 |
Eli Lilly And Company |
Pre-mixes of glp-1 and basal insulin
|
US6676641B2
(en)
|
2001-09-05 |
2004-01-13 |
Futura Medical Technologies, Inc. |
Retractable hypodermic syringe
|
BR0213377A
(pt)
|
2001-10-18 |
2006-05-23 |
Bristol Myers Squibb Co |
mìmico de peptìdeo semelhante ao glucagon 1 humano e seu uso no tratamento de diabetes e condições relacionadas
|
CA2463803A1
(en)
|
2001-10-19 |
2003-05-01 |
Eli Lilly And Company |
Biphasic mixtures of glp-1 and insulin
|
US20050148497A1
(en)
|
2002-02-20 |
2005-07-07 |
Khan Mohammed A. |
Method for administering glp-1 molecules
|
AU2003209475A1
(en)
|
2002-03-07 |
2003-09-16 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
EP1344533B1
(en)
|
2002-03-15 |
2006-08-23 |
Natimmune A/S |
Pharmaceutical compositions comprising mannose binding lectin
|
JP2005535569A
(ja)
|
2002-04-04 |
2005-11-24 |
ノボ・ノルデイスク・エー/エス |
Glp−1アゴニスト及び心臓血管合併症
|
CA2491685A1
(en)
|
2002-07-09 |
2004-01-15 |
Sandoz Ag |
Liquid formulations with high concentration of human growth hormone (hgh) comprising 1,2-prolpylene glycol
|
US6945961B2
(en)
|
2002-07-10 |
2005-09-20 |
Novo Nordisk A/S |
Injection device
|
WO2004007003A1
(en)
|
2002-07-10 |
2004-01-22 |
Novo Nordisk A/S |
An injection device with a dose setting limiter
|
EP1391794A1
(en)
|
2002-07-23 |
2004-02-25 |
Novo Nordisk A/S |
Device with time indicating means
|
JP2005536300A
(ja)
|
2002-08-29 |
2005-12-02 |
ノボ・ノルデイスク・エー/エス |
前方格納型注入デバイス
|
CA2500195C
(en)
|
2002-09-24 |
2009-07-21 |
Shl Medical Ab |
Injecting device
|
US7273921B2
(en)
|
2002-09-25 |
2007-09-25 |
Novo Nordisk A/S |
Method for producing acylated peptides
|
EP1546187B1
(en)
|
2002-09-25 |
2008-06-04 |
Novo Nordisk A/S |
Purification process comprising microfiltration at elevated temperatures
|
AU2003278929A1
(en)
|
2002-10-18 |
2004-05-13 |
Amylin Pharmaceuticals, Inc. |
Treatment of pancreatitis with amylin
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
EP1610811A4
(en)
|
2002-12-17 |
2008-03-26 |
Amylin Pharmaceuticals Inc |
PREVENTING AND TREATING CARDIAC ERRORS
|
US20050019400A1
(en)
|
2003-01-27 |
2005-01-27 |
Deveney Thomas William |
Controlled-release drug delivery system
|
GB0304822D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
GB0304824D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
GB0304823D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
GB0306642D0
(en)
|
2003-03-22 |
2003-04-30 |
Dca Design Int Ltd |
Improvements in and relating to an injector for a medical product
|
GB0308267D0
(en)
|
2003-04-10 |
2003-05-14 |
Dca Design Int Ltd |
Improvements in and relating to a pen-type injector
|
WO2004089985A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Stable pharmaceutical compositions
|
EP1631308B1
(en)
|
2003-05-30 |
2013-07-31 |
Amylin Pharmaceuticals, LLC |
Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
ATE541582T1
(de)
|
2003-06-03 |
2012-02-15 |
Novo Nordisk As |
Stabilisierte pharmazeutische glp-1 peptid zusammensetzungen
|
CN1812807A
(zh)
*
|
2003-06-03 |
2006-08-02 |
诺沃挪第克公司 |
稳定化的药物肽组合物
|
CA2527743A1
(en)
|
2003-06-03 |
2004-12-09 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
CA2530263C
(en)
|
2003-08-12 |
2012-04-17 |
Eli Lilly And Company |
Medication dispensing apparatus with triple screw threads for mechanical advantage
|
WO2005021026A2
(en)
|
2003-08-29 |
2005-03-10 |
Amylin Pharmaceuticals, Inc. |
Methods for treating or ameliorating ghrelin-associated diseases and disorders
|
SI2932981T1
(sl)
|
2003-09-19 |
2021-11-30 |
Novo Nordisk A/S |
Albumin-vezavni derivati GLP-1
|
PE20050444A1
(es)
|
2003-10-31 |
2005-08-09 |
Takeda Pharmaceutical |
Compuestos de piridina como inhibidores de la peptidasa
|
SI1682180T1
(sl)
|
2003-11-04 |
2010-03-31 |
Novartis Vaccines & Diagnostic |
Antagonist anti cd monoklonskih antiteles in postopek za njihovo uporabo
|
PT2489364E
(pt)
|
2003-11-06 |
2015-04-16 |
Seattle Genetics Inc |
Compostos de monometilvalina conjugados com anticorpos
|
ATE525083T1
(de)
|
2003-11-13 |
2011-10-15 |
Novo Nordisk As |
Pharmazeutische zusammensetzung umfassend eine insulinotrope glp-1(7-37) analoge, asp(b28)- insulin, und eine oberflächenaktive verbindung
|
US20060287221A1
(en)
|
2003-11-13 |
2006-12-21 |
Novo Nordisk A/S |
Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
|
EP1687019B1
(en)
|
2003-11-20 |
2017-11-22 |
Novo Nordisk A/S |
Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
|
WO2005058252A2
(en)
|
2003-12-16 |
2005-06-30 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Glp-1 pharmaceutical compositions
|
US20060286129A1
(en)
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
US20050143303A1
(en)
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
BRPI0507623A
(pt)
|
2004-02-11 |
2007-07-03 |
Amylin Pharmaceuticals Inc |
peptìdeos da famìlia da amilina e métodos para prepará-los e empregá-los
|
EP1765406A4
(en)
|
2004-05-21 |
2012-11-28 |
Mediplex Corp |
ADDITIVES FOR IMPROVED MUCOSAL ABSORPTION OF THERAPEUTIC AGENTS
|
US7448385B2
(en)
|
2004-06-07 |
2008-11-11 |
Purepharm Inc. |
Nasal adaptation of an oral inhaler device
|
EP2316446A1
(en)
|
2004-06-11 |
2011-05-04 |
Novo Nordisk A/S |
Counteracting drug-induced obesity using GLP-1 agonists
|
WO2006000567A2
(en)
|
2004-06-28 |
2006-01-05 |
Novo Nordisk A/S |
Use of glp-1 receptor agonists and / or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i i and impaired pancreatic beta-cell function
|
EP2457580A1
(en)
|
2004-08-25 |
2012-05-30 |
The UAB Research Foundation |
Absorption enhancers for drug administration
|
KR101123549B1
(ko)
|
2004-11-01 |
2012-04-18 |
아밀린 파마슈티칼스, 인크. |
비만 및 관련 장애의 치료
|
US20080125361A1
(en)
|
2004-11-12 |
2008-05-29 |
Novo Nordisk A/S |
Stable Formulations Of Peptides
|
WO2006051103A2
(en)
|
2004-11-12 |
2006-05-18 |
Novo Nordisk A/S |
Stable formulations of peptides
|
JP5324098B2
(ja)
|
2004-11-16 |
2013-10-23 |
アルケルメス ファーマ アイルランド リミテッド |
注射可能なナノ粒子のオランザピン製剤
|
US7833707B2
(en)
|
2004-12-30 |
2010-11-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of overexpression and recovery of porcine circovirus type 2 ORF2
|
AU2006207744B2
(en)
|
2005-01-21 |
2011-08-11 |
Novo Nordisk A/S |
An automatic injection device with a top release mechanism
|
DK2620450T3
(en)
|
2005-03-08 |
2019-02-04 |
Pfizer Prod Inc |
Antibody Compositions against CTLA-4
|
US8834891B2
(en)
|
2005-03-14 |
2014-09-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Immunogenic compositions comprising Lawsonia intracellularis
|
TWI362392B
(en)
*
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
WO2007014051A2
(en)
|
2005-07-22 |
2007-02-01 |
Amylin Pharmaceuticals, Inc. |
Use of amylin and amylin agonists as cardioprotective or myoprotective agents
|
WO2007022518A2
(en)
|
2005-08-19 |
2007-02-22 |
Amylin Pharmaceuticals, Inc. |
New uses of glucoregulatory proteins
|
BRPI0620080A2
(pt)
|
2005-12-19 |
2011-11-01 |
Comentis Inc |
formulações tópicas de mecamilamina para adminstração ocular e usos das mesma
|
DK2371382T3
(en)
|
2005-12-29 |
2016-06-13 |
Boehringer Ingelheim Vetmedica Inc |
Use of a PCV2 immunogenic composition to reduce the clinical signs in swine
|
AU2007238574B2
(en)
|
2006-04-13 |
2011-08-18 |
Ipsen Pharma S.A.S. |
Pharmaceutical compositions of hGLP-1, exendin-4 and analogs thereof
|
MX2009000748A
(es)
|
2006-07-18 |
2009-03-31 |
Centocor Inc |
Mimeticuerpos de peptido-1 similar a glucagon de humano, composiciones, metodos y usos.
|
TWI489984B
(zh)
|
2006-08-04 |
2015-07-01 |
Wyeth Corp |
用於非經腸道傳輸化合物之配方及其用途
|
UY30820A1
(es)
|
2006-12-21 |
2008-07-03 |
Centocor Inc |
Uso de agonistas del receptor de glp-1 de accion prolongada para mejorar la sensibilidad a la insulina y los perfiles lipidicos
|
GB0704846D0
(en)
|
2007-03-13 |
2007-04-18 |
Futura Medical Dev Ltd |
Topical pharmaceutical formulation
|
CN104000779A
(zh)
|
2007-04-23 |
2014-08-27 |
精达制药公司 |
促胰岛素释放肽的混悬制剂及其应用
|
EP2190460B1
(en)
|
2007-09-05 |
2014-12-17 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
US20100311643A1
(en)
|
2007-09-11 |
2010-12-09 |
Dorian Bevec |
Use of glp-1 as a therapeutic agent
|
WO2009051992A1
(en)
|
2007-10-19 |
2009-04-23 |
Bausch & Lomb Incorporated |
Compositions and methods for treating diseases involving ocular angiogenesis by inhibiting one or more selected receptor tyrosine kinases
|
US20100323955A1
(en)
|
2007-11-14 |
2010-12-23 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity and obesity related diseases and disorders
|
CN102026666B
(zh)
|
2007-12-11 |
2013-10-16 |
常山凯捷健生物药物研发(河北)有限公司 |
促胰岛素肽缀合物制剂
|
JP5703226B2
(ja)
|
2008-10-21 |
2015-04-15 |
ノヴォ ノルディスク アー/エス |
アミリン誘導体
|
US8748375B2
(en)
|
2009-03-17 |
2014-06-10 |
Amylin Pharmaceuticals, Llc |
Methods for affecting body composition using amylin agonists
|
CN102458521B
(zh)
|
2009-06-04 |
2014-06-04 |
诺沃—诺迪斯克保健股份有限公司 |
具有活塞联接布置的混合设备
|
CN102548583B
(zh)
|
2009-07-31 |
2015-04-22 |
赛诺菲-安万特德国有限公司 |
包含胰岛素连接物缀合物的前药
|
KR101759499B1
(ko)
|
2009-07-31 |
2017-07-19 |
사노피-아벤티스 도이칠란트 게엠베하 |
지속형 인슐린 조성물
|
WO2011050008A2
(en)
|
2009-10-19 |
2011-04-28 |
Amylin Pharmaceuticals, Inc. |
Combination therapy comprising administration of an amylinomimetic and a pyy peptidomimetic for effecting weight loss and for treating obesity and related metabolic conditions and disorders
|
KR20120104316A
(ko)
|
2009-12-10 |
2012-09-20 |
메르크 파텐트 게엠베하 |
올리고펩티드, 바람직하게는 실렌기티드를 포함하는 약학 조성물
|
MX2012006634A
(es)
|
2009-12-16 |
2012-06-21 |
Novo Nordisk As |
Derivados de peptidos tipo glucagon 1 de doble acilato.
|
WO2011104378A1
(en)
|
2010-02-26 |
2011-09-01 |
Novo Nordisk A/S |
Peptides for treatment of obesity
|
WO2011109787A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Methods of administering insulinotropic peptides
|
WO2011109784A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Formulation of insulinotropic peptide conjugates
|
KR20130018410A
(ko)
|
2010-03-26 |
2013-02-21 |
노보 노르디스크 에이/에스 |
새로운 글루카곤 유사체
|
EA201390182A1
(ru)
|
2010-07-28 |
2014-01-30 |
АМИЛИН ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Соединения-агонисты рецептора glp-1, содержащие стабилизированные области
|
EP2438930A1
(en)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrugs comprising an exendin linker conjugate
|
JP6231386B2
(ja)
|
2010-11-09 |
2017-11-15 |
ノヴォ ノルディスク アー/エス |
リンカーを有する二重アシル化されたglp−1誘導体
|
WO2012098187A1
(en)
|
2011-01-19 |
2012-07-26 |
Novo Nordisk A/S |
Glp-1 compositions
|
RU2635188C2
(ru)
|
2011-02-04 |
2017-11-09 |
ИнФёрст Хэлткэр Лимитед |
Композиции и способы для лечения хронического воспаления и воспалительных заболеваний
|
US20130035281A1
(en)
|
2011-02-09 |
2013-02-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
AU2012241894B2
(en)
|
2011-04-12 |
2015-12-03 |
Novo Nordisk A/S |
Double-acylated GLP-1 derivatives
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
PL2718316T3
(pl)
|
2011-06-10 |
2020-06-29 |
Novo Nordisk A/S |
Polipeptydy
|
JP6040464B2
(ja)
|
2011-07-08 |
2016-12-07 |
アエゲリオン・ファーマシューティカルズ・インコーポレイテッドAegerion Pharmaceuticals, Inc. |
作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
|
US9132170B2
(en)
|
2011-07-29 |
2015-09-15 |
Case Western Reserve University |
Compositions and methods for treating cognitive deficits
|
WO2013037690A1
(en)
|
2011-09-06 |
2013-03-21 |
Novo Nordisk A/S |
Glp-1 derivatives
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對bcma之e3以及cd3的結合分子
|
US20150038417A1
(en)
|
2011-12-09 |
2015-02-05 |
Novo Nordisk A/S |
GLP-1 Agonists
|
CN104185639B
(zh)
|
2012-03-01 |
2018-06-19 |
诺和诺德股份有限公司 |
Glp-1前体药物
|
CN102579350B
(zh)
|
2012-03-02 |
2013-04-24 |
海南灵康制药有限公司 |
右旋布洛芬脂质体固体制剂
|
EP3505176A1
(en)
|
2012-04-02 |
2019-07-03 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of secreted proteins
|
WO2013151729A1
(en)
|
2012-04-03 |
2013-10-10 |
Trustees Of Boston University |
Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders
|
WO2013156594A1
(en)
|
2012-04-19 |
2013-10-24 |
Novo Nordisk A/S |
Human amylin analogues
|
CN104519902B
(zh)
|
2012-05-08 |
2017-10-27 |
诺和诺德股份有限公司 |
双酰化glp‑1衍生物
|
EP2846824B1
(en)
|
2012-05-08 |
2017-04-05 |
Novo Nordisk A/S |
Double-acylated glp-1 derivatives
|
US20150174209A1
(en)
|
2012-05-25 |
2015-06-25 |
Amylin Pharmaceuticals. Llc |
Insulin-pramlintide compositions and methods for making and using them
|
TR201909016T4
(tr)
|
2012-06-19 |
2019-07-22 |
Debiopharm Int Sa |
(E)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamidin ön ilaç türevleri.
|
US9764003B2
(en)
*
|
2012-07-01 |
2017-09-19 |
Novo Nordisk A/S |
Use of long-acting GLP-1 peptides
|
EP2908844A1
(en)
*
|
2012-10-17 |
2015-08-26 |
Novo Nordisk A/S |
Fatty acid acylated amino acids for oral peptide delivery
|
EP3778623A1
(en)
|
2013-03-15 |
2021-02-17 |
Rhythm Pharmaceuticals, Inc. |
Pharmaceutical compositions
|
PT2991671T
(pt)
|
2013-05-02 |
2018-11-05 |
Novo Nordisk As |
Dosagem oral de compostos de glp-1
|
KR20160005364A
(ko)
|
2013-05-10 |
2016-01-14 |
님버스 아폴로, 인코포레이티드 |
Acc 억제제 및 이의 용도
|
EP3010531A1
(en)
|
2013-06-21 |
2016-04-27 |
Novo Nordisk A/S |
Novel uses of glp-1 receptor agonists in patients treated with insulin and/or suffering from type 1 diabetes
|
CA2916311A1
(en)
|
2013-07-04 |
2015-01-08 |
Novo Nordisk A/S |
Derivatives of glp-1 like peptides, and uses thereof
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
CN103405753B
(zh)
*
|
2013-08-13 |
2016-05-11 |
上海仁会生物制药股份有限公司 |
稳定的促胰岛素分泌肽水针药物组合物
|
EP3129041B1
(en)
|
2014-04-07 |
2019-06-12 |
Novo Nordisk A/S |
Double-acylated glp-1 compounds
|
RU2017101667A
(ru)
|
2014-06-25 |
2018-07-26 |
ГЛЭКСОСМИТКЛАЙН ЭлЭлСи |
Фармацевтические композиции
|
WO2016001862A1
(en)
|
2014-07-04 |
2016-01-07 |
Wockhardt Limited |
Extended release formulations of insulins
|
WO2016038521A1
(en)
|
2014-09-08 |
2016-03-17 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical compositions of liraglutide
|
WO2016083499A1
(en)
*
|
2014-11-27 |
2016-06-02 |
Novo Nordisk A/S |
Glp-1 derivatives and uses thereof
|
CN105777872B
(zh)
*
|
2014-12-16 |
2019-06-07 |
深圳翰宇药业股份有限公司 |
一种萨摩鲁肽的纯化方法
|
EP3295952B1
(en)
|
2015-05-13 |
2021-02-17 |
Hangzhou Jiuyuan Gene Engineering Co., Ltd |
Pharmaceutical formulation comprising glp-1 analogue and preparation method thereof
|
TW201706291A
(zh)
|
2015-07-10 |
2017-02-16 |
賽諾菲公司 |
作為選擇性肽雙重glp-1/升糖素受體促效劑之新毒蜥外泌肽(exendin-4)衍生物
|
WO2017149070A1
(en)
|
2016-03-03 |
2017-09-08 |
Novo Nordisk A/S |
Glp-1 derivatives and uses thereof
|
RU2768283C2
(ru)
|
2016-04-28 |
2022-03-23 |
Ново Нордиск А/С |
Семаглутид при сердечно-сосудистых состояниях
|
JP2019535835A
(ja)
|
2016-11-22 |
2019-12-12 |
バイオコン リサーチ リミテッドBiocon Research Limited |
Glp−1類似体の医薬組成物
|
GB201621987D0
(en)
|
2016-12-22 |
2017-02-08 |
Archer Virgil L See Archer Sheri A Arecor Ltd |
Novel composition
|
CN110545836A
(zh)
|
2017-01-24 |
2019-12-06 |
马克雷根有限公司 |
用载脂蛋白模拟物治疗与年龄有关的黄斑变性和其他眼部疾病
|
KR20200044016A
(ko)
|
2017-08-24 |
2020-04-28 |
노보 노르디스크 에이/에스 |
Glp-1 조성물 및 그 용도
|
AR114162A1
(es)
|
2017-12-21 |
2020-07-29 |
Sanofi Sa |
Composición farmacéutica líquida
|
TWI705820B
(zh)
|
2018-06-22 |
2020-10-01 |
美商美國禮來大藥廠 |
Gip/glp1促效劑組合物
|
WO2020004368A1
(ja)
|
2018-06-25 |
2020-01-02 |
Jcrファーマ株式会社 |
蛋白質含有水性液剤
|
BR112022013795A2
(pt)
|
2020-02-18 |
2022-09-13 |
Novo Nordisk As |
Composição farmacêutica líquida, e, kit
|